AU2566292A - Enzyme capture assay - Google Patents

Enzyme capture assay

Info

Publication number
AU2566292A
AU2566292A AU25662/92A AU2566292A AU2566292A AU 2566292 A AU2566292 A AU 2566292A AU 25662/92 A AU25662/92 A AU 25662/92A AU 2566292 A AU2566292 A AU 2566292A AU 2566292 A AU2566292 A AU 2566292A
Authority
AU
Australia
Prior art keywords
sache
enzyme
ligand
human
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25662/92A
Other languages
English (en)
Inventor
David Mark Brennand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AVALON BIOSCIENCES Ltd
Original Assignee
Kodak Clinical Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodak Clinical Diagnostics Ltd filed Critical Kodak Clinical Diagnostics Ltd
Publication of AU2566292A publication Critical patent/AU2566292A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU25662/92A 1991-09-09 1992-09-09 Enzyme capture assay Abandoned AU2566292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919119240A GB9119240D0 (en) 1991-09-09 1991-09-09 Enzyme capture assay for human secretory acetyl cholinesterase
GB9119240 1991-09-09

Publications (1)

Publication Number Publication Date
AU2566292A true AU2566292A (en) 1993-04-05

Family

ID=10701127

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25662/92A Abandoned AU2566292A (en) 1991-09-09 1992-09-09 Enzyme capture assay

Country Status (6)

Country Link
EP (1) EP0604509A1 (ja)
JP (1) JPH06510851A (ja)
AU (1) AU2566292A (ja)
CA (1) CA2118709A1 (ja)
GB (1) GB9119240D0 (ja)
WO (1) WO1993005398A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1734367A1 (en) * 2005-06-14 2006-12-20 Cellzome Ag Process for the identification of novel enzyme interacting compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59208462A (ja) * 1983-04-29 1984-11-26 バイオウィッテッカー・インコーポレーテッド キモパパインの分析法
IL75553A (en) * 1985-06-18 1993-07-08 Yeda Res & Dev Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
WO1990003577A1 (en) * 1988-09-30 1990-04-05 The University Of Vermont And State Agricultural College Immunoassays for catalytically-active, serine proteases
GB8927389D0 (en) * 1989-12-04 1990-01-31 Jehanli Ahmed M T Monoclonal antibodies

Also Published As

Publication number Publication date
CA2118709A1 (en) 1993-03-18
WO1993005398A1 (en) 1993-03-18
JPH06510851A (ja) 1994-12-01
EP0604509A1 (en) 1994-07-06
GB9119240D0 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
EP0615129B1 (en) Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis or primary sclerosing cholangitis
US5118606A (en) Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
US7462495B2 (en) Methods and compositions for use in diagnosing and characterizing chronic immune disease
JP2000510581A (ja) 血小板顆粒蛋白質を用いた血小板数アッセイ
CA2393127C (en) Diagnostic assay for stroke
WO2006121099A1 (ja) 血清糖蛋白質をバイオマーカーとするアルツハイマー病の診断方法
EP0856158B1 (en) Assay for the diagnosis of dementia
EP0968429B1 (en) Method and kit for determining the phenotype of a haptoglobin and use thereof
US5834214A (en) Detection of pancreatitis-associated protein for screening for cystic fibrosis
US6080554A (en) Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
GB2218100A (en) Conjugates for the detection and/or quantification of antigenic substances in body fluids
AU2566292A (en) Enzyme capture assay
CA2223278A1 (en) Method for the isolation of lipoprotein (a) allowing for the subsequent quantification of its mass and cholesterol content
RU2210074C2 (ru) Иммунологический анализ человеческого медуллазина и диагностика рассеянного склероза с его помощью
US7713515B2 (en) Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis
JP2915530B2 (ja) ラミニン フラグメント
RU2197736C1 (ru) Реагент для иммуноферментного анализа и способ иммуноферментного тестирования специфических антител при описторхозе, вызываемом печеночной трематодой opisthorhis felineus
WO2014177701A1 (en) Process for diagnosing a human subject with diseases affecting the kidneys, or at risk of acquiring diseases affecting the kidneys
KR20010074986A (ko) 췌장 기능 장애를 검출하기 위한 진단 방법
CA2218535A1 (en) Altered protein expression in hypoxic trophoblasts
EP0506682A1 (en) Method of determining anti-xanthine oxidase antibody
JPH08285846A (ja) ポール・バンネル抗体測定試薬並びにポール・バンネル抗原